Standalone PAT of Rs.3.09 crore at Beta Drugs in HY2 FY19-20
Beta Drugs announced its standalone and consolidated financial results for the half year ended on March 31, 2020.
Company : Beta Drugs Limited
Standalone total revenue at Beta Drugs was Rs.31.38 crore followed by net profit of Rs.3.09 crore and earning per share stood at Rs.3.26 in HY2 for FY2019-20.
Standalone revenue for the year was Rs.65.73 crore and net profit reached Rs.7.09 crore.
The companys consolidated total revenue at Beta Drugs was Rs.44.40 crore, net profit was Rs.4.29 crore and earning per share stood at Rs.4.53 in HY2 for FY2019-20.
Consolidated revenue for the tear was Rs.91.21crore and profit after tax reached Rs.9.41 crore
|Current Year Upto||Previous Year Upto||Previous Year|